Galapagos | GLPG - Interest Expense On Debt


Galapagos reported EUR1.72M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
argenx SE USD 828K 165K Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
Genmab DKK 10M 27M Dec/2025
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Incyte USD 582K 10K Dec/2025
Merck EUR 121M 5M Dec/2025
Neurocrine Biosciences USD 1.1M 0 Mar/2024
Novartis USD 304M 23M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 49M 29M Dec/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025